Status:
RECRUITING
Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia
Lead Sponsor:
Groupe Francophone des Myelodysplasies
Conditions:
Myelodysplastic Syndromes
Leukemia, Myeloid, Acute
Eligibility:
All Genders
18+ years
Brief Summary
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS a...
Detailed Description
The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS a...
Eligibility Criteria
Inclusion
- Male or female
- Age \> 18 years
- Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia
- Able and willing to provide written informed consent
Exclusion
- Age \<18 years
- Patient is unwilling or unable to give consent
Key Trial Info
Start Date :
July 7 2003
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
January 5 2031
Estimated Enrollment :
6990 Patients enrolled
Trial Details
Trial ID
NCT06956755
Start Date
July 7 2003
End Date
January 5 2031
Last Update
May 6 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Aspasia Stamatoullas
Rouen, France, 76038